9D9 is a commonly employed anti-CD272 immunoglobulin in immune studies , especially regarding tumor immune treatment . Primarily, developed for blocking CTLA-4 function , 9D9 successfully interferes with the inhibitory regulatory messages that CTLA-4 delivers to T cells , consequently promoting anti